Biopharma companies have long been looking for a way to go beyond the molecule/pill.The nascent but growing digital therapeutics industry set to grow to $10 billion by 2023 may be guiding that way forward, according to a panel discussion on the second day of the DTx (Digital Therapeutics) West conference in San Mateo, California.
{iframe}https://medcitynews.com/2019/03/sanofi-bayer-and-roche-execs-underscore-the-value-of-digital-therapeutics/{/iframe}